These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22874487)

  • 1. [Neuroenhancement in healthy subject? A French case study].
    Micoulaud-Franchi JA; Vion-Dury J; Lancon C
    Therapie; 2012; 67(3):213-21. PubMed ID: 22874487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people.
    Boot BP; Partridge B; Hall W
    Neurocase; 2012 Jun; 18(3):181-4. PubMed ID: 22007842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroenhancement: wisdom of the masses or "false phronesis"?
    Larriviere D; Williams MA
    Clin Pharmacol Ther; 2010 Oct; 88(4):459-61. PubMed ID: 20856244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine.
    Repantis D; Bovy L; Ohla K; Kühn S; Dresler M
    Psychopharmacology (Berl); 2021 Feb; 238(2):441-451. PubMed ID: 33201262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of university students using stimulants for cognitive enhancement: a pilot study].
    Franke AG; Schwarze CE; Christmann M; Bonertz C; Hildt E; Lieb K
    Psychiatr Prax; 2012 May; 39(4):174-80. PubMed ID: 22318482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Methylphenidate for Cognitive Enhancement in Young Healthy Adults: The Clinical and Ethical Debates.
    Koren G; Korn L
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):100-102. PubMed ID: 33666399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology.
    Cakic V
    J Med Ethics; 2009 Oct; 35(10):611-5. PubMed ID: 19793941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive enhancement in children and adolescents: is it in their best interests?
    Gaucher N; Payot A; Racine E
    Acta Paediatr; 2013 Dec; 102(12):1118-24. PubMed ID: 24033708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dealing with requests for pharmacological cognitive enhancement from healthy students.
    Chandramouleeswaran S; Edwin NC; Rajaleelan W
    Indian J Med Ethics; 2016; 1(3):196. PubMed ID: 27474703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications.
    Graf WD; Nagel SK; Epstein LG; Miller G; Nass R; Larriviere D
    Neurology; 2013 Mar; 80(13):1251-60. PubMed ID: 23486879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement.
    Franke AG; Lieb K; Hildt E
    PLoS One; 2012; 7(6):e40047. PubMed ID: 22768218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of methylphenidate among students: the future of enhancement?
    Outram SM
    J Med Ethics; 2010 Apr; 36(4):198-202. PubMed ID: 20338928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroenhancement and mood enhancement – Physiological and pharmacodynamical background.
    Weiergräber M; Ehninger D; Broich K
    Med Monatsschr Pharm; 2017 Apr; 40(4):154-64. PubMed ID: 29952165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Case of Pharmacological Neuroenhancement: Medical, Judicial and Ethical Aspects from a German Perspective.
    Franke AG; Northoff R; Hildt E
    Pharmacopsychiatry; 2015 Nov; 48(7):256-64. PubMed ID: 26252723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives.
    Daubner J; Arshaad MI; Henseler C; Hescheler J; Ehninger D; Broich K; Rawashdeh O; Papazoglou A; Weiergräber M
    Neural Plast; 2021; 2021():8823383. PubMed ID: 33519929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine.
    Svetlov SI; Kobeissy FH; Gold MS
    J Addict Dis; 2007; 26(4):1-6. PubMed ID: 18032226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognition enhancers between treating and doping the mind.
    Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S
    Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine use by children: the quest for enhancement.
    Bramstedt KA
    Subst Use Misuse; 2007; 42(8):1237-51. PubMed ID: 17674233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implications of methylphenidate use by healthy medical students and doctors in South Africa.
    Beyer C; Staunton C; Moodley K
    BMC Med Ethics; 2014 Mar; 15():20. PubMed ID: 24592964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions.
    Musten LM; Firestone P; Pisterman S; Bennett S; Mercer J
    J Am Acad Child Adolesc Psychiatry; 1997 Oct; 36(10):1407-15. PubMed ID: 9334554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.